JP2021530988A5 - - Google Patents
Info
- Publication number
- JP2021530988A5 JP2021530988A5 JP2021500866A JP2021500866A JP2021530988A5 JP 2021530988 A5 JP2021530988 A5 JP 2021530988A5 JP 2021500866 A JP2021500866 A JP 2021500866A JP 2021500866 A JP2021500866 A JP 2021500866A JP 2021530988 A5 JP2021530988 A5 JP 2021530988A5
- Authority
- JP
- Japan
- Prior art keywords
- cas9
- combination according
- mrna
- sequence
- mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024135748A JP2024164090A (ja) | 2018-07-13 | 2024-08-15 | 遺伝子編集の高特異性を達成する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862697955P | 2018-07-13 | 2018-07-13 | |
| US62/697,955 | 2018-07-13 | ||
| PCT/US2019/041551 WO2020014577A1 (en) | 2018-07-13 | 2019-07-12 | Methods of achieving high specificity of genome editing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024135748A Division JP2024164090A (ja) | 2018-07-13 | 2024-08-15 | 遺伝子編集の高特異性を達成する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530988A JP2021530988A (ja) | 2021-11-18 |
| JP2021530988A5 true JP2021530988A5 (https=) | 2022-07-19 |
| JP7590952B2 JP7590952B2 (ja) | 2024-11-27 |
Family
ID=69141767
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500866A Active JP7590952B2 (ja) | 2018-07-13 | 2019-07-12 | 遺伝子編集の高特異性を達成する方法 |
| JP2024135748A Pending JP2024164090A (ja) | 2018-07-13 | 2024-08-15 | 遺伝子編集の高特異性を達成する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024135748A Pending JP2024164090A (ja) | 2018-07-13 | 2024-08-15 | 遺伝子編集の高特異性を達成する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220195403A1 (https=) |
| EP (1) | EP3820503A4 (https=) |
| JP (2) | JP7590952B2 (https=) |
| KR (1) | KR20210031482A (https=) |
| CA (1) | CA3106162A1 (https=) |
| TW (1) | TW202023605A (https=) |
| WO (1) | WO2020014577A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015330699B2 (en) | 2014-10-10 | 2021-12-02 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| US11866726B2 (en) | 2017-07-14 | 2024-01-09 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
| EP3823633A4 (en) | 2018-06-29 | 2023-05-03 | Editas Medicine, Inc. | SYNTHETIC LEAD MOLECULES, COMPOSITIONS AND METHODS RELATED THERETO |
| US12521451B2 (en) | 2019-11-08 | 2026-01-13 | Regeneron Pharmaceuticals, Inc. | CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy |
| EP4426828A1 (en) | 2021-11-01 | 2024-09-11 | Tome Biosciences, Inc. | Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo |
| AU2022420615A1 (en) | 2021-12-22 | 2024-07-04 | Tome Biosciences, Inc. | Co-delivery of a gene editor construct and a donor template |
| JP2025507990A (ja) * | 2022-03-04 | 2025-03-21 | エピジェニック・セラピューティクス・インコーポレイテッド | ゲノム編集の組成物及び方法 |
| WO2023205744A1 (en) | 2022-04-20 | 2023-10-26 | Tome Biosciences, Inc. | Programmable gene insertion compositions |
| WO2023215831A1 (en) | 2022-05-04 | 2023-11-09 | Tome Biosciences, Inc. | Guide rna compositions for programmable gene insertion |
| WO2023225670A2 (en) | 2022-05-20 | 2023-11-23 | Tome Biosciences, Inc. | Ex vivo programmable gene insertion |
| WO2024020587A2 (en) | 2022-07-22 | 2024-01-25 | Tome Biosciences, Inc. | Pleiopluripotent stem cell programmable gene insertion |
| CN115312122B (zh) * | 2022-10-12 | 2022-12-16 | 之江实验室 | 一种CRISPR-Cas酶可突变位点推荐方法和装置 |
| WO2024138194A1 (en) | 2022-12-22 | 2024-06-27 | Tome Biosciences, Inc. | Platforms, compositions, and methods for in vivo programmable gene insertion |
| WO2024234006A1 (en) | 2023-05-11 | 2024-11-14 | Tome Biosciences, Inc. | Systems, compositions, and methods for targeting liver sinusodial endothelial cells (lsecs) |
| AU2024270764A1 (en) | 2023-05-15 | 2025-12-04 | Nchroma Bio, Inc. | Compositions and methods for epigenetic regulation of hbv gene expression |
| WO2025050069A1 (en) | 2023-09-01 | 2025-03-06 | Tome Biosciences, Inc. | Programmable gene insertion using engineered integration enzymes |
| EP4677108A1 (en) | 2024-04-22 | 2026-01-14 | Basecamp Research Ltd | Method and compositions for detecting off-target editing |
| WO2025224182A2 (en) | 2024-04-23 | 2025-10-30 | Basecamp Research Ltd | Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013003475A1 (en) * | 2011-06-27 | 2013-01-03 | Cellscript, Inc. | Inhibition of innate immune response |
| US9234213B2 (en) * | 2013-03-15 | 2016-01-12 | System Biosciences, Llc | Compositions and methods directed to CRISPR/Cas genomic engineering systems |
| CN105492611A (zh) * | 2013-06-17 | 2016-04-13 | 布罗德研究所有限公司 | 用于序列操纵的优化的crispr-cas双切口酶系统、方法以及组合物 |
| CA2917348A1 (en) * | 2013-07-11 | 2015-01-15 | Moderna Therapeutics, Inc. | Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use |
| US9228207B2 (en) * | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
| CA2969619A1 (en) * | 2014-12-03 | 2016-06-09 | Agilent Technologies, Inc. | Guide rna with chemical modifications |
| EP3904366A1 (en) * | 2014-12-16 | 2021-11-03 | Novartis AG | End capped nucleic acid molecules |
| CN104611368B (zh) * | 2015-01-15 | 2018-05-25 | 中国科学院广州生物医药与健康研究院 | 重组后不产生移码突变的载体、在爪蛙基因组中进行基因定点敲入的方法及应用 |
| EP3274454B1 (en) * | 2015-03-25 | 2021-08-25 | Editas Medicine, Inc. | Crispr/cas-related methods, compositions and components |
| US10188750B1 (en) * | 2015-10-23 | 2019-01-29 | University Of South Florida | Self-replicating cell selective gene delivery compositions, methods, and uses thereof |
| WO2017160662A1 (en) * | 2016-03-12 | 2017-09-21 | The Regents Of The University Of California | Biodegradable vectors for efficient rna delivery |
| ES2962711T3 (es) * | 2016-12-20 | 2024-03-20 | Bristol Myers Squibb Co | Métodos para aumentar la eficacia de la reparación dirigida por homología (HDR) en el genoma celular |
-
2019
- 2019-07-12 WO PCT/US2019/041551 patent/WO2020014577A1/en not_active Ceased
- 2019-07-12 EP EP19834647.0A patent/EP3820503A4/en active Pending
- 2019-07-12 CA CA3106162A patent/CA3106162A1/en active Pending
- 2019-07-12 US US17/259,998 patent/US20220195403A1/en active Pending
- 2019-07-12 JP JP2021500866A patent/JP7590952B2/ja active Active
- 2019-07-12 KR KR1020217003832A patent/KR20210031482A/ko active Pending
- 2019-07-12 TW TW108124751A patent/TW202023605A/zh unknown
-
2024
- 2024-08-15 JP JP2024135748A patent/JP2024164090A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530988A5 (https=) | ||
| US20240247262A1 (en) | Crispr/cas system and method for genome editing and modulating transcription | |
| US20230091847A1 (en) | Compositions and methods for improving homogeneity of dna generated using a crispr/cas9 cleavage system | |
| US11225649B2 (en) | Engineered nucleic-acid targeting nucleic acids | |
| JP2021118726A5 (https=) | ||
| AU2020262371B2 (en) | Nucleic acid constructs and methods for their manufacture | |
| JP6960950B2 (ja) | 配列操作のための系、方法および最適化ガイド組成物のエンジニアリング | |
| US12065667B2 (en) | Modified Cpf1 MRNA, modified guide RNA, and uses thereof | |
| US9868962B2 (en) | CRISPR hybrid DNA/RNA polynucleotides and methods of use | |
| CN111836894B (zh) | 用于使用CRISPR/Cpf1系统进行基因组编辑的组合物及其用途 | |
| US10526590B2 (en) | Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination | |
| EP3178935B1 (en) | Genome editing using campylobacter jejuni crispr/cas system-derived rgen | |
| US12612612B2 (en) | Methods for exon skipping and gene knockout using base editors | |
| CA3236512A1 (en) | Compositions and methods for treating hemoglobinopathies | |
| US20170058272A1 (en) | Directed nucleic acid repair | |
| FI3802807T3 (fi) | Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi | |
| BR112020026246A2 (pt) | composições, sistemas e métodos de amplificação com base em nickase dupla crispr | |
| JP2020517299A (ja) | 縦列反復配列を有するドナーｄｎａ修復鋳型を使用する部位特異的なｄｎａ改変 | |
| JP2026016493A (ja) | 修飾二重鎖ドナー鋳型 | |
| CN104560995A (zh) | 一对特异识别猪H11位点的sgRNA及其编码DNA和应用 | |
| JP2024533448A (ja) | 化学修飾を有するガイドｒｎａを使用する方法 | |
| WO2023169482A1 (en) | Modified crispr-based gene editing system and methods of use | |
| EP4230737A1 (en) | Novel enhanced base editing or revising fusion protein and use thereof | |
| JP2023542962A (ja) | 新規の改良された塩基編集または編集用融合タンパク質およびその用途 | |
| KR20230016751A (ko) | 염기 편집기 및 이의 용도 |